Abstract

Telemedicine has emerged as a pivotal component of contemporary diabetes care, driven by advances in digital 
health technologies, evolving healthcare delivery models, and the exigencies of the COVID-19 pandemic. This 
narrative review examines the foundations, modalities, clinical effectiveness, and implementation considerations of 
telemedicine in diabetes management. Drawing on evidence from randomized controlled trials, systematic reviews, 
and health systems analyses, the review evaluates key telemedicine modalities, including synchronous tele
consultations, asynchronous communication, remote monitoring, and mobile health applications. Findings indicate 
that telemedicine interventions are associated with improvements in glycemic control, lipid profiles, patient 
satisfaction, and self-management behaviors across diverse settings, including low- and middle-income countries. 
Patient experience and engagement are generally favorable, particularly in remote monitoring programs, though 
variability in adherence and accessibility persists. The review further explores health system integration 
challenges, equity and digital divide concerns, economic implications, and ethical, legal, and data security 
considerations. Despite promising outcomes, heterogeneity in study designs, outcome measures, and intervention 
components limits definitive conclusions regarding long-term effectiveness and cost-efficiency. The review 
highlights the need for standardized evaluation frameworks, robust economic analyses, and equity-focused 
implementation strategies to optimize telemedicine’s role in sustainable and patient-centered diabetes care.